InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
82.77
(
0.00%
)
Bitcoin
63,881.61
(
1.58%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DonShimoda

Send PM Follow Ignore
Followers 19
Posts 727
Boards Moderated 0
Alias Born 11/10/2009

DonShimoda

Re: lax20m post# 13905

Monday, 11/07/2011 1:50:01 PM

Monday, November 07, 2011 1:50:01 PM

Post# of 80490
"Management reiterated that it is keeping US marketing rights and is finalizing its plans for Europe, although it appears
likely to maintain EU rights as well. It has many good term sheets from potential partners. Ariad is moving ahead with a
Japanese IND in 1H:12 independent of the deliberations on Asian strategies. Management emphasized that the company is
not out raising money and it has cash through the end of 2012 without potential milestone on ridaforolimus approval
($25M)"

http://www.healthace.com/rssfeed/Oncology_Report_101911M.pdf
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up